SLM Corporation 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SLM) 2025-10-24
Seeking Alpha· 2025-10-24 14:32
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Sonic Automotive: Q3 Performance Had Mixed Takeaways (Rating Downgrade)
Seeking Alpha· 2025-10-24 14:32
Asia Value & Moat Stocks is a research service for value investors seeking Asia-listed stocks with a huge gap between price and intrinsic value, leaning towards deep value balance sheet bargains (i.e. buying assets at a discount e.g. net cash stocks, net-nets, low P/B stocks, sum-of-the-parts discounts) and wide moat stocks (i.e. buying earnings power at a discount in great companies like "Magic Formula" stocks, high-quality businesses, hidden champions and wide moat compounders). Sign up here to get starte ...
Primis Financial Corp. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:FRST) 2025-10-24
Seeking Alpha· 2025-10-24 14:31
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q3 Earnings
ZACKS· 2025-10-24 14:31
Key Takeaways Lilly's oncology sales are projected at $2.58B for Q3 2025, up over 15% year over year.Verzenio demand and pricing gains are expected to drive growth despite currency and competition.New drug Inluriyo won FDA approval but will not contribute sales until post-Q3 launch.While Eli Lilly (LLY) is a market leader in the GLP-1 segment, thanks to its tirzepatide medicines Mounjaro and Zepbound (for obesity), the company also generates a meaningful portion of revenues from its oncology franchise. Sale ...
Orchid Island Capital, Inc. 2025 Q3 - Results - Earnings Call Presentation (NYSE:ORC) 2025-10-24
Seeking Alpha· 2025-10-24 14:31
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Wall Street Analysts Look Bullish on Dell Technologies (DELL): Should You Buy?
ZACKS· 2025-10-24 14:31
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Let's take a look at what these Wall Street heavyweights have to say about Dell Technologies (DELL) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Dell Technologies currently has an average brokerage r ...
Compared to Estimates, Gentex (GNTX) Q3 Earnings: A Look at Key Metrics
ZACKS· 2025-10-24 14:31
For the quarter ended September 2025, Gentex (GNTX) reported revenue of $655.24 million, up 7.7% over the same period last year. EPS came in at $0.46, compared to $0.53 in the year-ago quarter.The reported revenue represents a surprise of -2.75% over the Zacks Consensus Estimate of $673.73 million. With the consensus EPS estimate being $0.47, the EPS surprise was -2.13%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine thei ...
Brokers Suggest Investing in Strategy (MSTR): Read This Before Placing a Bet
ZACKS· 2025-10-24 14:31
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Strategy (MSTR) .Strategy currently has an average brokerage reco ...
Compared to Estimates, First Hawaiian (FHB) Q3 Earnings: A Look at Key Metrics
ZACKS· 2025-10-24 14:31
First Hawaiian (FHB) reported $226.39 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 7.8%. EPS of $0.59 for the same period compares to $0.48 a year ago.The reported revenue represents a surprise of +3.71% over the Zacks Consensus Estimate of $218.28 million. With the consensus EPS estimate being $0.52, the EPS surprise was +13.46%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wa ...
Wall Street Analysts Look Bullish on Toyota Motor (TM): Should You Buy?
ZACKS· 2025-10-24 14:31
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Let's take a look at what these Wall Street heavyweights have to say about Toyota Motor Corporation (TM) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Toyota Motor curren ...